Position in MRK
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$9,242,105
-$1,037,998 QoQ
Shares Held
71,923
-15.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#779
of 3,778 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Carnegie Investment Counsel holds $159,457,484 across 11 Drug Manufacturers - General names. MRK ranks #5 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
182,419 | $45,903,917 | |
| 2 | AMGN |
Amgen Inc
|
103,528 | $37,489,559 | |
| 3 | JNJ |
Johnson & Johnson
|
132,112 | $33,552,484 | |
| 4 | LLY |
ELI LILLY & Co
|
11,114 | $13,330,466 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
71,923 | $9,242,105 | |
| 6 | NVO |
Novo Nordisk A S
|
170,256 | $8,162,072 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
35,216 | $4,449,189 | |
| 8 | PFE |
Pfizer Inc
|
129,803 | $3,125,656 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,242,105 | 71,923 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $10,280,103 | 85,461 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $9,127,620 | 86,715 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $6,283,503 | 74,866 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $5,186,879 | 65,524 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $5,690,424 | 63,396 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $3,057,318 | 30,733 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $3,185,244 | 28,049 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $3,603,199 | 29,105 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $4,570,484 | 34,638 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $3,765,114 | 34,536 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $4,332,547 | 42,084 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $5,013,695 | 43,450 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $4,741,163 | 44,564 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $5,271,567 | 47,513 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $3,755,951 | 43,613 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $3,969,359 | 43,538 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $3,148,914 | 38,378 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $2,557,246 | 33,367 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $2,217,772 | 29,527 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $2,323,223 | 29,873 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $2,154,049 | 27,942 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $2,185,695 | 26,720 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $2,264,370 | 27,298 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $2,151,785 | 27,826 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $2,131,160 | 27,699 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||